Hyperglycemia and acute coronary syndrome: A systematic review of hyperglycemia's impact on ACS

American Journal of Therapeutics

Volumn 17, Issue 2, 2010, Pages

  Loomba, Rohit Seth ^a   Arora, Rohit ^b  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

ACS; Coronary syndrome; Hyperglycemia

Indexed keywords

GLUCOSE; INSULIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; CARDIOVASCULAR RISK; CLINICAL RESEARCH; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

ACUTE CORONARY SYNDROME; BLOOD GLUCOSE; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; TIME FACTORS;

EID: 77949922212     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mjt.0000369908.44628.89     Document Type: Review

References (16)

1. Capes S, Hunt D, Malmberg K, et al. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes. Lancet. 2000;355: 773-778.
2. Deedwania P, Kosiborod M, Barrett E, et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2008;25:1610-1619.
3. Marfella R, Siniscalchi M, Esposito K, et al. Effect of stress hyperglycemia on acute myocardial infarction. Diabetes Care. 2003;26:3129-3135.
4. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation. 2005; 111:3078-3086.
5. Kosiborod M, Inzucchi SE, Krumholz HM, et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation. 2008;117:1018-1027.
6. Cheung NW, Wong VW, McLean M. The Hyperglycemia Intensive Insulin Infusion in Infarction Study. Diabetes Care. 2006;29:765-770.
7. Goyal A, Mahaffey KW, Garg J, et al. Prognostic significance of the changein glucose level in the first 24h after myocardial infarction. Eur Heart J. 2006;27: 1289-1297.
8. Blankenberg S, Tiret L, Bickel C, et al. Interleukin-18 Is a strong predictor of cardiovascular death in stable and unstable angina. Circulation. 2002;106:24-30.
9. Kersten JR, Toller WG, Tessmer JP, et al. Hyperglycemia reduces coronary collateral blood flow through a nitric oxide mediated mechanism. Am J Physiol Heart Circ Physiol. 2001;281:2097-2104.
10. Giugliano D, Marfella R, Coppola L, et al. Vascular effects of acute hyperglycemia in humans are reversed by Larginine: evidence for reduced availability of nitric oxide during hyhperglycemia. Circulation. 1997;95:1783-1790.
11. Timmer JR, Ottervanger JP, Boer MJ, et al. Zwolle Myocardial Infarction Study Group. Hyperglycemisa is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005;45:999-1002.
12. Morohoshi M, Fujisawa K, Uchimara I, et al. Glucose dependent interleukin 6 and tumor necrosis factor in production by human peripheral blood monocytes in vitro. Diabetes. 1996;45:954-959.
13. Das U. Is insulin an endogenous cardioprotector. Crit Care. 2002;6:389-393.
14. Gearhart M, Parbhoo S. Hyperglycemia in the critically ill patient. AACN Clin Issues. 2006;17:50-55.
15. Malmberg K, Norhammar A, Wedel H, et al. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long term results from DIGAMI Study. Circulation. 1999;99: 2626-2632.
16. Malmberg K, Ryden L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects of mortality and morbidity. Eur Heart J. 2005;26: 650-661